Genmab — Februar 2021

[deleted-user]

was not looking for 1 to 1 connect. in that term. But it seems like people forget the risk and then having a wakeup call suddenly which also w
ill affect peers

[deleted-user]

should be brief. As you mention Genmab has a broad foundation that has been recognized by value in the market

[Helge_LarsenPI-redaktør]

God morgen.

[Helge_LarsenPI-redaktør]

Asien: Usikkerhed får investorerne til at hente gevinster hjem - NY
https://www.proinvestor.com/investornyt/672258/asien-usikkerhed-far-investorerne-til-at-hente-gevinster-hjem-ny

[Helge_LarsenPI-redaktør]

Torsdagens aviser med Mærsk, Topdanmark og MT Højgaard:
https://www.proinvestor.com/investornyt/672255/torsdagens-aviser-med-maersk-topdanmark-og-mt-hojgaard

[bibob]

God morgen.

[bibob]

Looking for new immuno Therapeutics in RRMM https://www.onclive.com/view/looking-to-novel-immunotherapeutics-in-relapsed-refractory-multiple-myeloma

[E_L]

Genmab is excited to present at #JSMO2021. Japanese Society of Medical Oncology Management. https://twitter.com/Genmab/status/1362190140735709184

[E_L]

"In addition to cancer, we may consider partnership opportunities to address any disease area where antibody-based therapies may be effective, including autoimmune conditions, inflammation, central nervous system conditions and infectious diseases." i wonder if this statement is meant only for partnerships or if Genmab wants to expand their horizon themselves https://www.genmab.com/partnering/#page-approach

[StockBull]

https://nbg1.your-objectstorage.com/proinvestor-dev/forum/boards/91112_genmab_feb_18.JPG Genmab holder sig fint omkring den opadgående midterlinie og kurs 3000 ser stadig realistisk ud inden for kommende 8-10 mdr

[E_L]

Darzalex for
AL amyloidosis
on EMA COMP agenda for -Orphan designated products for discussion prior to adoption of
CHMP opinion

[E_L]

Nature, Blood cancer journal - Epcoritamab induces potent anti-tumor activity against malignant B-cells from patients with DLBCL, FL and MCL, irrespective of prior CD20 monoclonal antibody treatment https://www.nature.com/articles/s41408-021-00430-6

[Helge_LarsenPI-redaktør]

God morgen.

[Helge_LarsenPI-redaktør]

Asien: Høje renter begynder at tynge investorernes indstilling - NY: https://www.proinvestor.com/investornyt/672302/asien-hoje-renter-begynder-at-tynge-investorernes-indstilling-ny

[Helge_LarsenPI-redaktør]

Fredagens aviser med Vestas, Tryg og
Arlahttps://www.proinvestor.com/investornyt/672299/fredagens-aviser-med-vestas-tryg-og-arla

[Plimsoller]

God morgen

[bibob]

God morgen.

[bibob]

OncLive. Results from the phase 3. ANDROMEDA study.

[bibob]

https://www.onclive.com/view/results-from-the-phase-3-andromeda-study?seriesVid=1&?utm_source=sfmc&utm_medium=email&utm_campaign=2-18-21_BMS-21-OSD1002_OncLive_Multiple Myeloma CC eNews_BMS,Revlimid_NON_US_Send&eKey=amFuYm9ydXAxOTc4QGdtYWlsLmNvbQ==

[bibob]

https://www.onclive.com/view/monoclonal-antibodies-prove-to-be-novel-therapeutics-for-myeloma?utm_source=sfmc&utm_medium=email&utm_campaign=2-18-21_BMS-21-OSD1002_OncLive_Multiple Myeloma CC eNews_BMS,Revlimid_NON_US_Send&eKey=amFuYm9ydXAxOTc4QGdtYWlsLmNvbQ==